Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Pouya Azar, Nickie Mathew, Daljeet Mahal, James S.H. Wong, Jean N. Westenberg, Christian G. Schütz & Mark K. Greenwald. (2023) Developing A Rapid Transfer from Opioid Full Agonist to Buprenorphine: “Ultrarapid Micro-Dosing” Proof of Concept. Journal of Psychoactive Drugs 55:1, pages 94-101.
Read now
Read now
Joshua MacAusland-Berg, Amy Wiebe, Radhika Marwah & Katelyn Halpape. (2022) Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report. Canadian Journal of Pain 6:1, pages 135-141.
Read now
Read now
Jose Perez Martell, Jaya Sri Konakanchi & Roopa Sethi. (2022) Treating opioid use disorder with rapid micro induction technique of sublingual buprenorphine/naloxone in an outpatient setting—a case report. Journal of Addictive Diseases 40:3, pages 439-443.
Read now
Read now
Articles from other publishers (15)
John P. Murray, Geoffrey Pucci, George Weyer, Mim Ari, Sarah Dickson & Angela Kerins. (2023) Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series. Addiction Science & Clinical Practice 18:1.
Crossref
Crossref
Adams K. K.Miech E. J.Sobieraj D. M.. (2022) Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis. Addiction Science & Clinical Practice 17:1.
Crossref
Crossref
Lindsay A. Jablonski, Alia R. Bodnar & Rosalyn W. Stewart. (2022) Development of an intravenous low-dose buprenorphine initiation protocol. Drug and Alcohol Dependence 237, pages 109541.
Crossref
Crossref
Shawn M. Cohen, Melissa B. Weimer, Ximena A. Levander, Alyssa M. Peckham, Jeanette M. Tetrault & Kenneth L. Morford. (2022) Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach. Journal of Addiction Medicine 16:4, pages 399-406.
Crossref
Crossref
Clive G. Wilson, Leon Aarons, Patrick Augustijns, Joachim Brouwers, Adam S. Darwich, Tom De Waal, Grzegorz Garbacz, Simone Hansmann, Dagmara Hoc, Anela Ivanova, Mirko Koziolek, Christos Reppas, Philipp Schick, Maria Vertzoni & J. Arturo García-Horsman. (2022) Integration of advanced methods and models to study drug absorption and related processes: An UNGAP perspective. European Journal of Pharmaceutical Sciences 172, pages 106100.
Crossref
Crossref
Lauren A. Spreen, Emma N. Dittmar, Kyle C. Quirk & Michael A. Smith. (2022) Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42:5, pages 411-427.
Crossref
Crossref
Kyle Quirk & Maximillian Stevenson. (2022) Buprenorphine Microdosing for the Pain and Palliative Care Clinician. Journal of Palliative Medicine 25:1, pages 145-154.
Crossref
Crossref
James S. H. Wong, Mohammadali Nikoo, Jean N. Westenberg, Janet G. Suen, Jennifer Y. C. Wong, Reinhard M. Krausz, Christian G. Schütz, Marc Vogel, Jesse A. Sidhu, Jessica Moe, Shane Arishenkoff, Donald Griesdale, Nickie Mathew & Pouya Azar. (2021) Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial. Addiction Science & Clinical Practice 16:1.
Crossref
Crossref
Madison Irwin, William Gunther, Patricia Keefer, D'Anna Saul, Sharon A. Singh, Jennifer Wright & Michael A. Smith. (2021) Buprenorphine for Chronic Pain in a Pediatric Patient With Sickle-Cell Disease. Journal of Pain and Symptom Management 62:5, pages 1086-1091.
Crossref
Crossref
Madison IrwinKetti S. PetersenMichael A. Smith. (2021) Rapid Buprenorphine Induction for Cancer Pain in Pregnancy. Journal of Palliative Medicine 24:8, pages 1257-1262.
Crossref
Crossref
Saeed Ahmed, Siddhi Bhivandkar, Brady B. Lonergan & Joji Suzuki. (2020) Microinduction of Buprenorphine/Naloxone: A Review of the Literature. The American Journal on Addictions 30:4, pages 305-315.
Crossref
Crossref
Jessica Moe, Fiona O'Sullivan, Corinne M. Hohl, Mary M. Doyle-Waters, Claire Ronsley, Raymond Cho, Qixin Liu & Pouya Azar. (2021) Short communication: Systematic review on effectiveness of micro-induction approaches to buprenorphine initiation. Addictive Behaviors 114, pages 106740.
Crossref
Crossref
Bradley M. Buchheit, Timothy Joslin, Helen N. Turner & Trisha E. Wong. (2020) Ambulatory microdose induction of buprenorphine‐naloxone in two adolescent patients with sickle cell disease. Pediatric Blood & Cancer 68:1.
Crossref
Crossref
Jennifer Rozylo, Keren Mitchell, Mohammadali Nikoo, S. Elise Durante, Skye P. Barbic, Daniel Lin, Steve Mathias & Pouya Azar. (2020) Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach. Addiction Science & Clinical Practice 15:1.
Crossref
Crossref
Rupinder Brar, Nadia Fairbairn, Christy Sutherland & Seonaid Nolan. (2020) Use of a novel prescribing approach for the treatment of opioid use disorder: Buprenorphine/naloxone micro‐dosing – a case series. Drug and Alcohol Review 39:5, pages 588-594.
Crossref
Crossref